157 related articles for article (PubMed ID: 29217453)
41. Genome-Wide Analysis of mRNA Expression Profiling Identified Lung Cancer-Related Gene in Xuanwei, China.
Wu C; Song G; Xiong G; Lu L; Zhou X; Duan Y
Clin Lab; 2018 Sep; 64(9):1517-1526. PubMed ID: 30274024
[TBL] [Abstract][Full Text] [Related]
42. MiR‑221 and miR‑222 regulate cell cycle progression and affect chemosensitivity in breast cancer by targeting ANXA3.
Kim JY; Jung EJ; Kim JM; Son Y; Lee HS; Kwag SJ; Park JH; Cho JK; Kim HG; Park T; Jeong SH; Jeong CY; Ju YT
Exp Ther Med; 2023 Mar; 25(3):127. PubMed ID: 36845963
[TBL] [Abstract][Full Text] [Related]
43. Annexin A3 expression after stroke in the aged rat brain.
Kessler Ch; Junker H; Bălşeanu TA; Oprea B; Pirici D; Mogoantă L; Popa-Wagner A
Rom J Morphol Embryol; 2008; 49(1):27-35. PubMed ID: 18273499
[TBL] [Abstract][Full Text] [Related]
44. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
45. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
46. Annexin A3 as a Marker Protein for Microglia in the Central Nervous System of Rats.
Zhang Z; Li Z; Ma Z; Deng M; Xing M; Wu J; Jiang S; Wang Q; Guo Q; Zou W
Neural Plast; 2021; 2021():5575090. PubMed ID: 34221002
[TBL] [Abstract][Full Text] [Related]
47. [Knockdown of CART1 induces S phase arrest and inhibits invasion and migration of MDA-MB-231 breast cancer cells].
Guan T; Su L; Yi Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):474-8. PubMed ID: 27053613
[TBL] [Abstract][Full Text] [Related]
48. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
49. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
50. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
51. CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways.
Lian X; Jiao Y; Yang Y; Wang Z; Xuan Q; Liu H; Lu S; Wang Z; Liu Y; Li S; Yang Y; Guo L; Zhao L; Zhang Q
Med Oncol; 2015 Jan; 32(1):411. PubMed ID: 25476480
[TBL] [Abstract][Full Text] [Related]
52. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
53. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
Tilli TM; Carels N; Tuszynski JA; Pasdar M
Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
55. Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI-α silencing and overexpression.
Hooshmand S; Ghaderi A; Yusoff K; Thilakavathy K; Rosli R; Mojtahedi Z
Asian Pac J Cancer Prev; 2014; 15(7):3311-7. PubMed ID: 24815488
[TBL] [Abstract][Full Text] [Related]
56. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS
Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947
[TBL] [Abstract][Full Text] [Related]
57. Annexin A3 Regulates Early Blood Vessel Formation.
Meadows SM; Cleaver O
PLoS One; 2015; 10(7):e0132580. PubMed ID: 26182056
[TBL] [Abstract][Full Text] [Related]
58. Terrein inhibits migration of human breast cancer cells via inhibition of the Rho and Rac signaling pathways.
Kasorn A; Loison F; Kangsamaksin T; Jongrungruangchok S; Ponglikitmongkol M
Oncol Rep; 2018 Mar; 39(3):1378-1386. PubMed ID: 29328460
[TBL] [Abstract][Full Text] [Related]
59. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
60. Increased Expression of CD81 in Breast Cancer Tissue is Associated with Reduced Patient Prognosis and Increased Cell Migration and Proliferation in MDA-MB-231 and MDA-MB-435S Human Breast Cancer Cell Lines In Vitro.
Zhang N; Zuo L; Zheng H; Li G; Hu X
Med Sci Monit; 2018 Aug; 24():5739-5747. PubMed ID: 30117494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]